Regional Quantification of White Matter Hyperintensity in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease

Background/Aims: A quantitative method was applied to measure the volume of white matter hyperintensity (WMH) in different brain regions of subjects with Alzheimer’s disease (AD), mild cognitive impairment (MCI) and normal healthy age-matched controls, and the relationship between regional WMH and age and cognitive function was investigated. Methods: Fifty-six subjects were included in this study, 27 AD, 15 MCI and 14 normal age-matched controls. A user-friendly software was developed for WMH quantification in frontal, temporal, and parieto-occipital lobes. Mini-Mental State Examination and cognitive scores in performing naming, language fluency, and memory tasks were obtained for correlation analysis. Results: AD patients had the greatest total WMH volume, followed by MCI, then controls. However, there was a large variation within each group, and the difference did not reach a significant level. There was a positive linear correlation between the total WMH (p = 0.031) and the frontal WMH (p = 0.006) vs. age. After age correction the Boston Naming Test scores were negatively correlated with the total WMH volume in the AD (p = 0.03) and the control (p = 0.03) groups, and with the frontal WMH in controls (p = 0.01). Conclusion: We demonstrated a quantitative analysis method to measure regional WMH. Although WMH was not strongly associated with disease severity or cognition, it may provide a characteristic neuroimaging parameter in the study of AD development.

[1]  N. Raz.  Aging of the brain and its impact on cognitive performance: Integration of structural and functional findings. , 2000 .

[2]  T. Kemper,et al.  Neuroanatomical and neuropathological changes during aging and dementia. , 1994 .

[3]  W. M. van der Flier,et al.  Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD , 2004, Neurology.

[4]  K. Jellinger,et al.  Understanding the pathology of vascular cognitive impairment , 2005, Journal of the Neurological Sciences.

[5]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[6]  D. Head,et al.  Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. , 2004, Cerebral cortex.

[7]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[8]  Lars-Göran Nilsson,et al.  High Prevalence of White Matter Hyperintensities in Normal Aging: Relation to Blood Pressure and Cognition , 2003, Cortex.

[9]  H. Möller,et al.  Regional Distribution of White Matter Hyperintensities in Vascular Dementia, Alzheimer’s Disease and Healthy Aging , 2004, Dementia and Geriatric Cognitive Disorders.

[10]  H. Gertz,et al.  Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study , 2000, International journal of geriatric psychiatry.

[11]  D. Briley,et al.  Older people with impaired mobility have specific loci of periventricular abnormality on MRI. , 2002, Neurology.

[12]  E. Kaplan,et al.  The Boston naming test , 2001 .

[13]  F. Fazekas,et al.  MRI white matter hyperintensities , 1999, Neurology.

[14]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[15]  W. Rosen,et al.  Verbal fluency in aging and dementia , 1980 .

[16]  J. Morris,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.

[17]  Gal Sela,et al.  Utility of simultaneous brain, CSF and hyperintensity quantification in dementia , 2002, Psychiatry Research: Neuroimaging.

[18]  Lars-Olof Wahlund,et al.  Postmortem MRI and Histopathology of White Matter Changes in Alzheimer Brains , 2002, Dementia and Geriatric Cognitive Disorders.

[19]  A. Alavi,et al.  MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. , 1987, AJR. American journal of roentgenology.

[20]  E. Mori,et al.  Impact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease: A Quantitative Study , 2000, Stroke.

[21]  F. Fazekas,et al.  The relation of cerebral magnetic resonance signal hyperintensities to Alzheimer's disease , 1996, Journal of the Neurological Sciences.

[22]  A. Hofman,et al.  Cerebral white matter lesions and cognitive function: The Rotterdam scan study , 2000, Annals of neurology.

[23]  N. Schuff,et al.  Longitudinal volumetric MRI change and rate of cognitive decline , 2005, Neurology.

[24]  Matthias J. Müller,et al.  Ultrastructural Hippocampal and White Matter Alterations in Mild Cognitive Impairment: A Diffusion Tensor Imaging Study , 2004, Dementia and Geriatric Cognitive Disorders.

[25]  L. Thal,et al.  Relationship between Severe Amyloid Angiopathy, Apolipoprotein E Genotype, and Vascular Lesions in Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[26]  P. Scheltens,et al.  White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. , 1992, Brain : a journal of neurology.

[27]  C. Filley,et al.  The behavioral neurology of cerebral white matter , 1998, Neurology.

[28]  C. Jack,et al.  Mild cognitive impairment and Alzheimer disease: regional diffusivity of water. , 2001, Radiology.

[29]  A. Brun,et al.  A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study , 1986, Annals of neurology.

[30]  R Stewart,et al.  Cerebral white matter lesions and subjective cognitive dysfunction: The Rotterdam Scan Study , 2001, Neurology.

[31]  R. Reitan.  Validity of the Trail Making Test as an Indicator of Organic Brain Damage , 1958 .

[32]  Sheng-Kwei Song,et al.  Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition , 2004, Neurobiology of Disease.

[33]  Johan H. C. Reiber,et al.  Fully automatic segmentation of white matter hyperintensities in MR images of the elderly , 2005, NeuroImage.

[34]  F. Barkhof,et al.  CT and MRI Rating of White Matter Lesions , 2002, Cerebrovascular Diseases.

[35]  F. Gunning-Dixon,et al.  The cognitive correlates of white matter abnormalities in normal aging: a quantitative review. , 2000, Neuropsychology.

[36]  N. Schuff,et al.  MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease , 2001, Neurology.

[37]  F. Barkhof,et al.  Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging , 1995, Neurology.

[38]  J. Haxby,et al.  The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults , 1995, Neurology.

[39]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[40]  J. Garcìa,et al.  Pathogenesis of leukoaraiosis: a review. , 1997, Stroke.

[41]  Nick Bryan,et al.  Clinical Correlates of Ventricular and Sulcal Size on Cranial Magnetic Resonance Imaging of 3,301 Elderly People , 1999, Neuroepidemiology.

[42]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[43]  Eric E. Smith,et al.  Cerebral White Matter , 2008, Annals of the New York Academy of Sciences.

[44]  W. Markesbery,et al.  White matter volumes and periventricular white matter hyperintensities in aging and dementia , 2000, Neurology.

[45]  C. Reynolds,et al.  Wechsler memory scale-revised , 1988 .